BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  Flownamics
• 

  Breast cancer

  Lilly’s Oral SERD Wins FDA Go-Ahead for Breast Cancer

  Phase III data showed that Inluriyo improves progression-free survival versus standard endocrine therapy.

  September 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug pricing

  Trump Admin Readies Proposed Rule To Lower US Drug Prices

  Though details remain scant, the pending order is expected to be the latest effort in President Donald Trump’s campaign to bring drug prices down to the same level as economically similar countries.

  September 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Tariffs

  Trump Sets 100% Pharma Tariff Deadline for October 1

  Companies that have broken ground on or are actively constructing manufacturing facilities in the U.S. are exempted from the tariffs, according to President Donald Trump’s social media post on Thursday.

  September 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Immunology and inflammation

  Hansa Kidney Transplant Drug Aces Phase III Study, Headed to FDA

  Imlifidase, an IgG-destroying enzyme, could receive FDA approval in the second half of 2026 and hit peak sales of $306 million, according to William Blair.

  September 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Layoffs

  Heidelberg Pharma Misses Out on Royalty Payment, Plans 75% Workforce Cut

  The company was awaiting $70 million from HealthCare Royalty but missed an agreed-upon payment condition.

  September 26, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• Press Releases

  Arialys Therapeutics Receives FDA Rare Pediatric Disease Designation for ART5803 to Treat Anti-NMDA Receptor Encephalitis

  September 26, 2025

   · 

  4 min read
• Press Releases

  FDA Grants HemoSonics 510(k) Clearance to Expand Use of Its Quantra Hemostasis System to Obstetric Procedures

  September 26, 2025

   · 

  4 min read
• Press Releases

  GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

  September 26, 2025

   · 

  6 min read
• Press Releases

  Mint Pharmaceuticals Announces Partnership with Bayer Canada to Distribute ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada

  September 26, 2025

   · 

  3 min read